Finance

Lists
Why is 2575 up 4,28%?
Dive Deeper
2575:HKG
Xuanzhu Biopharmaceutical Co Ltd
8,42 HK$
+4,28%
(+0,35) 1D
15 қаз., 16:08:33 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2575...
Open
8,20 HK$
High
8,86 HK$
Low
8,18 HK$
Mkt. cap
4,36 млрд
Avg. vol.
3,25 млн
Volume
3,10 млн
52-wk high
96,90 HK$
52-wk low
8,00 HK$
EPS
-0,56 HK$
Shares outstanding
160,70 млн
No. of employees
344
Open
8,20 HK$
High
8,86 HK$
Low
8,18 HK$
Mkt. cap
4,36 млрд
Avg. vol.
3,25 млн
Volume
3,10 млн
52-wk high
96,90 HK$
52-wk low
8,00 HK$
EPS
-0,56 HK$
Shares outstanding
160,70 млн
No. of employees
344
News stories
From web sources and news partners
About Xuanzhu Biopharmaceutical Co Ltd
CEO-
Employees344
Founded2008
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
16,94 млн
16,94 млн
34,72 млн
34,72 млн
Cost of goods sold
6,67 млн
6,67 млн
27,05 млн
27,05 млн
Cost of revenue
6,67 млн
6,67 млн
27,05 млн
27,05 млн
Research and development expenses
20,24 млн
20,24 млн
13,75 млн
13,75 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
46,06 млн
46,06 млн
32,94 млн
32,94 млн
Operating expense
69,54 млн
69,54 млн
47,10 млн
47,10 млн
Total operating expenses
76,21 млн
76,21 млн
74,16 млн
74,16 млн
Operating income
-59,27 млн
-59,27 млн
-39,44 млн
-39,44 млн
Other non operating income
-7,68 млн
-7,68 млн
1,78 млн
1,78 млн
EBT including unusual items
-67,30 млн
-67,30 млн
-37,67 млн
-37,67 млн
EBT excluding unusual items
-68,95 млн
-68,95 млн
-37,67 млн
-37,67 млн
Income tax expense
-
-
3,00 мың
3,00 мың
Effective tax rate
-
-
-0,01%
-0,01%
Other operating expenses
3,24 млн
3,24 млн
413,50 м.
413,50 м.
Net income
-67,30 млн
-67,30 млн
-37,67 млн
-37,67 млн
Net profit margin
-397,30%
-397,30%
-108,49%
-108,49%
Earnings per share
-
-
-
-
Interest and investment income
1,65 млн
1,65 млн
-
-
Interest expense
-47,50 мың
-47,50 мың
-5,50 мың
-5,50 мың
Net interest expenses
1,60 млн
1,60 млн
-5,50 мың
-5,50 мың
Depreciation and amortization charges
-
-
-
-
EBITDA
-51,68 млн
-51,68 млн
-32,61 млн
-32,61 млн
Gain or loss from assets sale
-894,00 м.
-894,00 м.
-2,54 млн
-2,54 млн
AI content may include mistakes. Learn more
Google қолданбалары